跳至主要内容
临床试验/NCT04499976
NCT04499976Unknown4 期

Adjuvant Isonicotinic Acid Hydrazide (INH) With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage Among Women With One or More Previous Cesarean Deliveries.: A Randomized Controlled Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
240
试验地点
1
主要终点
number of patient with complete abortion

研究概览

简要总结

This study compares the success rate of Adjuvant isonicotinic acid hydrazide and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

详细描述

In the past, the role of laminaria and prostaglandins in cervical dilatation and reducing intraoperative complications of cervical dilatation have been proven . Misoprostol is a synthetic analogue of prostaglandin E1 used to treat and prevent gastric ulcers, which is now widely used in obstetrics and gynecology. Its applications in obstetrics and gynecology include medical abortion in the first and second trimesters of pregnancy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blind randomized controlled study

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age less than 70 days gestation (<10 wks).
  • Hemoglobin >10 g/dL.
  • BMI between 18.5 kg/m2 and 30 kg/m
  • Missed abortion
  • previous one or more cesarean deliveries

排除标准

  • Molar pregnancy
  • Fibroid uterus.
  • Uterine anomalies.
  • Coagulopathy
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or INH.

研究组 & 干预措施

INH

Experimental

3 tablets of isonicotinic acid hydrazide 300 mg will be given as single daily dose, 900 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.

干预措施: Isonicotinic Acid (Drug)

INH

Experimental

3 tablets of isonicotinic acid hydrazide 300 mg will be given as single daily dose, 900 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.

干预措施: Misoprostol (Drug)

Placebo Comparator

Placebo Comparator

three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses

干预措施: Placebo (Drug)

Placebo Comparator

Placebo Comparator

three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses

干预措施: Misoprostol (Drug)

结局指标

主要结局

number of patient with complete abortion

时间窗: 9 hours

number of patient with complete abortion

induction to abortion time

时间窗: 9 hours

induction to abortion time

次要结局

  • number of patient need for surgical evacuation of the products of conception(12 hours)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

hany farouk

A Professor

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验

Isonicotinic Acid Hydrazide Pretreatment With... | 临床试验